Recombinant multi-species KLK14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KLK14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the kallikrein subfamily of serine proteases that have diverse physiological functions such as regulation of blood pressure and desquamation. The altered expression of this gene is implicated in the progression of different cancers including breast and prostate tumors. The encoded protein is a precursor that is proteolytically processed to generate the functional enzyme. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
The Alternative Names of target: GK14,KLK-L6,KLK14,KLNM,Kallikrein-14,Kallikrein-like protein 6 (KLK-L6),Klk14,Klnm,hK14
Go
to KLK14 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T39195-Ag-1/ GM-Tg-hg-T39195-Ag-2 | Human KLK14 protein | Human |
GM-Tg-rg-T39195-Ag-1/ GM-Tg-rg-T39195-Ag-2 | Rat KLK14 protein | Rat |
GM-Tg-mg-T39195-Ag-1/ GM-Tg-mg-T39195-Ag-2 | Mouse KLK14 protein | Mouse |
GM-Tg-cynog-T39195-Ag-1/ GM-Tg-cynog-T39195-Ag-2 | Cynomolgus/Rhesus macaque KLK14 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T39195-Ag-1/ GM-Tg-felg-T39195-Ag-2 | Feline KLK14 protein | Feline |
GM-Tg-cang-T39195-Ag-1/ GM-Tg-cang-T39195-Ag-2 | Canine KLK14 protein | Canine |
GM-Tg-bovg-T39195-Ag-1/ GM-Tg-bovg-T39195-Ag-2 | Bovine KLK14 protein | Bovine |
GM-Tg-equg-T39195-Ag-1/ GM-Tg-equg-T39195-Ag-2 | Equine KLK14 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T39195-Ag-1/ GM-Tg-hg-T39195-Ag-2;
GM-Tg-rg-T39195-Ag-1/ GM-Tg-rg-T39195-Ag-2;
GM-Tg-mg-T39195-Ag-1/ GM-Tg-mg-T39195-Ag-2; GM-Tg-cynog-T39195-Ag-1/ GM-Tg-cynog-T39195-Ag-2; GM-Tg-felg-T39195-Ag-1/ GM-Tg-felg-T39195-Ag-2; GM-Tg-cang-T39195-Ag-1/ GM-Tg-cang-T39195-Ag-2; GM-Tg-bovg-T39195-Ag-1/ GM-Tg-bovg-T39195-Ag-2; GM-Tg-equg-T39195-Ag-1/ GM-Tg-equg-T39195-Ag-2 |
Products Name | KLK14 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | KLK14 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KLK14 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.